Search


	Podcast:		Biotech 2050 Podcast
	Episode:		37. Bringing new treatments to psychiatric orphan diseases, Ibs Mahmood, CEO, AMO Pharma
	Category:		Science & Medicine
	Duration:		00:23:35
	Publish Date:		2020-11-04 13:00:24
	Description:		Ibraheem Mahmood has an extensive life science and finance background that spans more than 20 years. His experience includes previous roles in Lifescience M&A and Fundraising at Nomura, Lifescience Equity Research at Investec and Business Development and Corporate Venture Capital at Shire Pharmaceuticals. He was co-founder, President and CEO of the clinical operations services company DrugDev, in which he raised over $50m in financing and he sold the business to IQVIA in 2017. Ibraheem studied medicine at the University of Oxford.
	Total Play:		0